当前位置:首页 - 行情中心 - 欧康医药(833230) - 财务分析

欧康医药

(833230)

  

流通市值:9.87亿  总市值:21.23亿
流通股本:3593.00万   总股本:7726.73万

欧康医药(833230)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.19亿元,每股收益0.26元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益40978.25万元,未分配利润9904.32万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产49289.67万元,负债8311.42万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入223,826,491.38132,309,174.8968,240,881.12242,810,197.99
营业总成本201,402,456.95118,189,219.0559,113,846.37228,406,123.63
营业利润23,680,748.4517,222,089.9110,319,424.7616,785,795.8
利润总额23,520,014.7917,060,913.7710,320,989.7616,757,721.8
净利润19,254,794.7613,625,149.638,561,888.4716,479,709.1
其他综合收益49,822.7775,970.96--23,834.47
综合收益总额19,304,617.5313,701,120.598,561,888.4716,455,874.63
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计234,863,474.45221,065,379.8252,728,292.63294,402,629.11
非流动资产合计258,033,224.26212,365,072.6184,997,343.03158,690,500.54
资产总计492,896,698.71433,430,452.4437,725,635.66453,093,129.65
流动负债合计77,884,969.0633,797,579.1628,750,898.555,844,213.67
非流动负债合计5,229,200.385,307,595.35,462,061.793,874,085.13
负债合计83,114,169.4439,105,174.4634,212,960.2959,718,298.8
归属于母公司股东权益合计409,173,051.3393,666,856.93402,724,951.69393,209,412.92
股东权益合计409,782,529.27394,325,277.94403,512,675.37393,374,830.85
负债和股东权益合计492,896,698.71433,430,452.4437,725,635.66453,093,129.65
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计247,734,027.69149,594,186.0471,388,750.19274,349,624.16
经营活动现金流出小计260,463,981.02172,290,624.3482,109,924.67238,215,584.96
经营活动产生的现金流量净额-12,729,953.33-22,696,438.3-10,721,174.4836,134,039.2
投资活动现金流入小计266,774,071.59176,295,475.98115,627,354.17247,045,538.06
投资活动现金流出小计279,797,535.41176,152,605.58123,081,056.48403,340,238.41
投资活动产生的现金流量净额-13,023,463.82142,870.4-7,453,702.31-156,294,700.35
筹资活动现金流入小计28,560,80919,710,590710,59047,803,925
筹资活动现金流出小计35,735,487.1635,512,612.5410,288,734.6668,874,548.57
筹资活动产生的现金流量净额-7,174,678.16-15,802,022.54-9,578,144.66-21,070,623.57
汇率变动对现金及现金等价物的影响374,924.95251,625.99183,136.6258,880.32
现金及现金等价物净增加额-32,553,170.36-38,103,964.45-27,569,884.85-140,972,404.4
期末现金及现金等价物余额18,967,926.2513,417,132.1624,000,446.4451,521,096.61
TOP↑